Middletown 7/30/2013 2:40:00 AM
News / Finance

Get a Stock Report on Exelixis, Inc. (OTCBB: EXEL) from LeadingStockAlerts.com

LeadingStockAlerts.com provides free stock reports for investors and day traders, simply by going to LeadingStockAlerts.com or by going to the link below, you can see all the daily information on Exelixis, Inc (OTCBB: EXEL). as a of 9:33am July 29, traded at $4.88 with a daily range between $4.87-$4.89.

Exelixis, Inc dropped 0.02 points from the close on Friday which was $4.90. The company’s 52 week range was $4.19-$6.95 with a volume of 27,563. Their average 3 month volume was 1,710,400. The market cap of the company was 896.95 million. You can get more information from your free stock report by going to leadingstockalerts.com or by going to the window below.

Exelixis, which is working on cancer cures, is under-the-radar for its successful lead compound, cabozantinib. This compound helped the company get its for the treatment of other forms of cancer. The company has 10 other compounds that are in phase 2 and phase 3 clinical trials.

About LeadingStockAlerts

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Many small cap and micro cap companies lack the recognition required to raise the resources needed to increase equity appreciation and liquidity. This community has traditionally been shunned by Wall Street Institutions and has been forced to look elsewhere for exposure.This site understands that there are many explosive companies waiting to be discovered by the retail investment community. These firms do not have the technology or time to introduce themselves to a wide range of potential investors. Our site allows its clients to focus on achieving their business goals while taking over the task of introducing the company to millions of potential investors.